Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The Lone Star state has emerged, by a long shot, as the nation’s leader in renewable energy generation, according to new data.
Microgrids could offer a stopgap solution until small modular reactors are ready for the market.
Novo Nordisk will sell its blockbuster weight-loss drug Wegovy for under half its normal price via a new direct-to-consumer online pharmacy.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Prada reported retail sales across its brands rose 18% last year as the company reportedly gears up to buy Versace from Capri Holdings.
Here’s the bad news: Auto manufacturing is a notoriously thin-margin industry, and tariffs could tear right through those margins.
The titanic port deal immediately made political waves, even as the seller, conglomerate CK Hutchison, denied politics were at play.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Eli Lilly last week announced a $27 billion investment in four different domestic manufacturing plants to boost weight-loss drug production.
As US-based streaming platforms chase audiences around the world, they’re increasingly committing to international productions.
On Wednesday, Bloomberg reported that one billion people are watching podcasts on the Google-owned YouTube every month.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.